111 related articles for article (PubMed ID: 31088619)
1. Identification of peptide inhibitors of matrix metalloproteinase 1 using an in-house assay system for the enzyme.
Min MW; Kim CE; Chauhan S; Park HJ; Park CS; Yoo TH; Kang TJ
Enzyme Microb Technol; 2019 Aug; 127():65-69. PubMed ID: 31088619
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics.
Edkins TJ; Alhadeff JA; Kwok V; Kalensky C; Rock MT; Vidmar TJ; Del Tito BJ
J Pharm Biomed Anal; 2012 Nov; 70():408-14. PubMed ID: 22854133
[TBL] [Abstract][Full Text] [Related]
3. Identification of Non-Zinc Binding Inhibitors of MMP-2 Through Virtual Screening and Subsequent Rescoring.
Shamsara J
Drug Res (Stuttg); 2018 Sep; 68(9):529-535. PubMed ID: 29614516
[TBL] [Abstract][Full Text] [Related]
4. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.
Ramezani M; Shamsara J
Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
Castro MM; Fuah J; Ali M; Sung M; Schulz J; Kondo MY; Fan X; Holt A; Schulz R
Biochem Pharmacol; 2013 Aug; 86(4):469-75. PubMed ID: 23774623
[TBL] [Abstract][Full Text] [Related]
6. An integrated structure- and pharmacophore-based MMP-12 virtual screening.
Ramezani M; Shamsara J
Mol Divers; 2018 May; 22(2):383-395. PubMed ID: 29423648
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
[TBL] [Abstract][Full Text] [Related]
9. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors.
Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P
Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
13. Identification of matrix metalloproteinase inhibitors by chemical arrays.
Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: Correlating in vitro targeted screening and docking.
Rathee D; Lather V; Grewal AS; Dureja H
Comput Biol Chem; 2019 Feb; 78():28-36. PubMed ID: 30497018
[TBL] [Abstract][Full Text] [Related]
15. Fusion Peptides CPU1 and CPU2 Inhibit Matrix Metalloproteinases and Protect Mice from Endotoxin Shock Within a Strict Time Window.
Qiu Z; Zhang F; Gong C; Xu H; Hu J
Inflammation; 2015 Dec; 38(6):2092-104. PubMed ID: 26111477
[TBL] [Abstract][Full Text] [Related]
16. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
18. Identification of Matrix Metalloproteinase-1-Suppressive Peptides in Feather Keratin Hydrolysate.
Jin HS; Song K; Baek JH; Lee JE; Kim DJ; Nam GW; Kang NJ; Lee DW
J Agric Food Chem; 2018 Dec; 66(48):12719-12729. PubMed ID: 30395462
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
Zhou J; Windsor LJ
J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase co-regulate axonal outgrowth of mouse retinal ganglion cells.
Gaublomme D; Buyens T; De Groef L; Stakenborg M; Janssens E; Ingvarsen S; Porse A; Behrendt N; Moons L
J Neurochem; 2014 Jun; 129(6):966-79. PubMed ID: 24611815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
